Nicotine pharmacokinetics of electronic cigarettes: a pooled data analysis from the literature.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharamacokinetics
Jacobson (2021)
Understanding potential mechanisms of harm: the drivers of electronic cigarette-induced changes in alveolar macrophages, neutrophils, and lung epithelial cells.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharamacokinetics
Jasper (2021)
E-cigarette use is associated with susceptibility to tobacco use among australian young adults.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Jongenelis (2019)
a comparison of product dependence among cigarette only, ENDS only, and dual users: Findings from Wave 3 (2015-2016) of the PaTh study.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Kaplan (2020)
Blood Nicotine Predicts the Behavioral Economic abuse Liability of Reduced-Nicotine Cigarettes.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Kaplan (2022)
Electronic Cigarettes to Vaporize Cannabis: Prevalence of Use and associated Factors among Current Electronic Cigarette Users in Germany (DEBRa Study).
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
Kastaun (2020)
Electronic Cigarette Use, Misuse, and harm.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Kathuria (2022)
a chocolate cake or a chocolate vape? Young adults describe their relationship with food and weight in the context of nicotine vaping.
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
Kechter (2022)
E-cigarette weight and appetite control beliefs and e-cigarette initiation in young adults.
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
Kechter (2023)
Electronic cigarette use and risk of cigarette and smokeless tobacco initiation among adolescent boys: a propensity score matched analysis.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Keller-hamilton (2021)